NIH-funded research R21 grant

Gentle focused ultrasound to change deep brain connections

Official title: Dose-Dependent Functional Connectivity Effects of Low-Intensity Focused Ultrasound Applied to Deep White Matter Tracts in Humans

Funded at Laureate Institute for Brain Research · NIH-11234316 · Data updated 2026-11-12

This project sees whether short bursts of low-intensity focused ultrasound can temporarily alter communication along deep brain pathways in healthy adults.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionLaureate Institute for Brain Research
NIH-funded
Lab location1 site (Tulsa, United States)
Project startDecember 1, 2024
Project endNovember 30, 2026
Funding year2026
Award (this year)$215,569
NIH project number5R21MH138911-02
Project IDNIH-11234316 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are healthy adults aged 21 or older who can undergo MRI and are willing to travel to the Tulsa research site.

Less likely to help

People seeking immediate treatment benefit, those with implanted medical devices, certain neurological conditions, or those who cannot have an MRI are unlikely to receive direct benefit from participation.

What this research studies

If you join, you'll be one of 60 healthy adults who receive small doses of gentle focused ultrasound aimed at deep white matter tracts that connect the thalamus with frontal regions. Participants are randomly assigned to two different ultrasound doses and receive MRI scans before and after the sessions to track changes in brain connectivity. The team measures how long and how strongly the ultrasound changes signaling using resting-state fMRI and carefully controlled sonication settings. The plan builds on a pilot that showed a single sonication can temporarily disconnect connected brain regions.

Why it matters

Potential benefit: If successful, this could provide a noninvasive way to adjust deep brain circuits and inform new treatments for mood and other brain disorders.

How similar studies have gone: Laboratory work and early human studies have shown LIFU can change gray matter activity and a pilot found white-matter effects, but systematic dose-response testing in white matter is still new.

Where this research is happening

  • Laureate Institute for Brain Research
    Tulsa, United States
    Active

Researchers

  • Principal investigator: Guinjoan, Salvador Martin — Laureate Institute for Brain Research
  • Study coordinator: Guinjoan, Salvador Martin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.